Marianne P. Allen

Array ( [id] => 4290709 [patent_doc_number] => 06211334 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Cell-cycle regulatory proteins, and uses related thereto' [patent_app_type] => 1 [patent_app_number] => 8/346147 [patent_app_country] => US [patent_app_date] => 1994-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 37810 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/211/06211334.pdf [firstpage_image] =>[orig_patent_app_number] => 346147 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3930500 [patent_doc_number] => 05980891 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Schizosaccharomyces-specific polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/345374 [patent_app_country] => US [patent_app_date] => 1994-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2021 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/980/05980891.pdf [firstpage_image] =>[orig_patent_app_number] => 345374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 975600 [patent_doc_number] => 06933276 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-23 [patent_title] => 'Methods of treating peripheral neuropathies using neurotrophin-3' [patent_app_type] => utility [patent_app_number] => 08/342457 [patent_app_country] => US [patent_app_date] => 1994-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 56 [patent_no_of_words] => 25329 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/933/06933276.pdf [firstpage_image] =>[orig_patent_app_number] => 08342457 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3655733 [patent_doc_number] => 05622862 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Assay systems for trkB neurotrophin activity' [patent_app_type] => 1 [patent_app_number] => 8/339578 [patent_app_country] => US [patent_app_date] => 1994-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 23 [patent_no_of_words] => 15316 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/622/05622862.pdf [firstpage_image] =>[orig_patent_app_number] => 339578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3769400 [patent_doc_number] => 05756348 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'DNA encoding a glycine transporter and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/240783 [patent_app_country] => US [patent_app_date] => 1994-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 21 [patent_no_of_words] => 18538 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756348.pdf [firstpage_image] =>[orig_patent_app_number] => 240783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3702219 [patent_doc_number] => 05674842 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Growth inhibitory peptide' [patent_app_type] => 1 [patent_app_number] => 8/329506 [patent_app_country] => US [patent_app_date] => 1994-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6147 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674842.pdf [firstpage_image] =>[orig_patent_app_number] => 329506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3854459 [patent_doc_number] => 05705334 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Uses for DNA structure-specific recognition protein' [patent_app_type] => 1 [patent_app_number] => 8/328809 [patent_app_country] => US [patent_app_date] => 1994-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 14533 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705334.pdf [firstpage_image] =>[orig_patent_app_number] => 328809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661315 [patent_doc_number] => 05656595 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Peptides having GDP exchange factor activity, nucleic acid sequences coding for these peptides, preparation and use' [patent_app_type] => 1 [patent_app_number] => 8/318831 [patent_app_country] => US [patent_app_date] => 1994-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 7021 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656595.pdf [firstpage_image] =>[orig_patent_app_number] => 318831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4159896 [patent_doc_number] => 06156876 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'D-type cyclin and uses related thereto' [patent_app_type] => 1 [patent_app_number] => 8/324526 [patent_app_country] => US [patent_app_date] => 1994-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 18 [patent_no_of_words] => 23179 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156876.pdf [firstpage_image] =>[orig_patent_app_number] => 324526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3659288 [patent_doc_number] => 05656454 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Endothelial cell-specific enhancer' [patent_app_type] => 1 [patent_app_number] => 8/317333 [patent_app_country] => US [patent_app_date] => 1994-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 6472 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656454.pdf [firstpage_image] =>[orig_patent_app_number] => 317333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4317948 [patent_doc_number] => 06248583 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Chromosomally-encoded membrane protein of borrelia burgdorferi' [patent_app_type] => 1 [patent_app_number] => 8/313412 [patent_app_country] => US [patent_app_date] => 1994-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11824 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248583.pdf [firstpage_image] =>[orig_patent_app_number] => 313412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3704068 [patent_doc_number] => 05654139 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Allelic variation of the serotonin 5HT.sub.2c receptor' [patent_app_type] => 1 [patent_app_number] => 8/310271 [patent_app_country] => US [patent_app_date] => 1994-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 9284 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/654/05654139.pdf [firstpage_image] =>[orig_patent_app_number] => 310271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622101 [patent_doc_number] => 05612198 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-18 [patent_title] => 'Production of insulin-like growth factor-1 in methylotrophic yeast cells' [patent_app_type] => 1 [patent_app_number] => 8/308196 [patent_app_country] => US [patent_app_date] => 1994-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 26899 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/612/05612198.pdf [firstpage_image] =>[orig_patent_app_number] => 308196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3552984 [patent_doc_number] => 05574008 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-12 [patent_title] => 'Biologically active fragments of glucagon-like insulinotropic peptide' [patent_app_type] => 1 [patent_app_number] => 8/297731 [patent_app_country] => US [patent_app_date] => 1994-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8748 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/574/05574008.pdf [firstpage_image] =>[orig_patent_app_number] => 297731 [rel_patent_id] =>[rel_patent_doc_number] =>)